MannKind
Price & Volume
Stats
See more52W Range | $2.23-$6.51 |
Market Cap | $1.2B |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $360.7M |
Revenue Growth (YoY) | 15.1% |
Gross Profit (12 Mos) | $272.8M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 5 days ago
MannKind Corporation (MNKD) Up 20% Since Afrezza FDA Approval
Yahoo Finance • 15 days ago
Is MannKind Corporation (MNKD) A Good Stock To Buy Now?
Yahoo Finance • last month
Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
Yahoo Finance • last month
Mankind: Afreezza Data At ADA 2026 Underscores Pediatric Safety And Expands Use In Diabetes Care
About
CEO | Dr. Michael E. Castagna Pharm.D. |
Address | 1 Casper Street, Danbury, CT, United States, 06810 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 591 |